The Valve Wire sealThe Valve Wire
July 15, 2026E. Nolan Beckett, MD · Editor
LIVE · 06:19 ET · JUL 15, 2026
EW · MDT · ABT · BSX ·
Surgical vs TranscatheterTuesday, July 14, 2026

TAVR vs. Redo Open Heart Surgery for Aortic Valve Stenosis: How to Choose the Right One for You - Yahoo Health

1 min read·By E. Nolan Beckett, MD·Source: Yahoo Health
From The Valve Wire

This is a consumer-facing Yahoo Health piece framing the TAVR-versus-redo-SAVR decision for patients with failing bioprosthetic aortic valves or native AS after prior cardiac surgery.

No trial data, no cohort, no new evidence — a patient education article.

The clinical reality behind the headline is more nuanced than any lifestyle piece can convey.

Valve-in-valve TAVR has become the default for failed surgical bioprostheses in most patients, with STS/ACC TVT Registry data supporting acceptable short-term outcomes, but the long-term durability signal remains thin and the risks — coronary obstruction, patient-prosthesis mismatch, sinus sequestration limiting future reintervention — are real and underappreciated in the lay press.

Source Abstract

TAVR vs. Redo Open Heart Surgery for Aortic Valve Stenosis: How to Choose the Right One for You Yahoo Health

Read the Original
Full article at Yahoo Health
Open at Yahoo Health
The Valve Wire summarizes; we link out to primary sources for verification.
More in Surgical vs Transcatheter
Elsewhere in Today’s Issue